| Faculty Development Press Release |
 |
 |
 |
| Written by Administrator |
| Thursday, 07 January 2010 16:47 |
|
The PhRMA Foundation announces that Sarah A. Holstein, M.D., Ph.D. an Assistant Professor in the Department of Internal Medicine at the University of Iowa Hospitals and Clinics has been awarded the 2010 Faculty Development AwardThe award was established in 1966 as part of a program designed to encourage clinical pharmacology teaching, training, and research, particularly in the years following formal training programs. Adequate funding provides opportunities for young investigators to realize their potential in the field of clinical pharmacology.The importance of this support is realized in every lab development that ultimately benefits a patient.Past award recipients who have achieved remarkable success as clinical pharmacologists include Terrence Blaschke, MD; Ray Hohl, MD, PhD, (1992); Elsa-Grace V. Giardina, MD, (1974); Jane Freedman, MD, (1999); and Scott Waldman, MD, PhD, FCP, (1990). In 2009 the award was given to Mara Becker, M.D.M.S.C.E., Assistant Professor in Pediatrics, at Children’s Mercy Hospital and Myaing M. Nyunt, M.D., Ph.D., Assistant Professor at the Bloomberg School of Public Health, Johns Hopkins University“The Faculty Development Award in Clinical Pharmacology positively affected my career because it provided support at a pivotal time in my academic development,” said Dr. Freedman. “This has allowed me to progress within my field of research and advance within my institution, as well as go on to achieve additional sources of funding.”Award recipients are selected by the Foundation’s Clinical Pharmacology Advisory Committee based on experience, research focus, and other criteria, including evidence of the candidate’s commitment to a career in clinical pharmacology. Eligible candidates have at least two years of residency training and two years of experience in a clinical pharmacology research program. Only full-time junior faculty members in the field of human clinical pharmacology are considered. Past research projects have ranged from laboratory studies of drug action to identification of new therapeutic targets. Proposals should fundamentally address the optimization of drug therapy.Award recipients receive two years of support in accordance with salaries disbursed by the applicant’s university. The award may be used for salary and fringe benefits only and will not exceed $120,000 per year.About the PhRMA Foundation For 45 years, the PhRMA Foundation has supported the field of drug discovery and the careers of scientific investigators, faculty members, and physicians. By funding the research of thousands of young scientists, the Foundation has helped pave the way for the future of pharmaceutical care.
|
| Last Updated ( Tuesday, 15 June 2010 10:28 ) |
(C) 2010 PhRMA Foundation - 950 F Street, N.W. Suite 300 Washington, DC 20004